BioStack Nets $9.5 Mn To Build Training Datasets For Medical AI
BioStack, founded in 2025, develops data infrastructure that aggregates fragmented clinical information from EHRs, medical imaging, and clinical notes to create datasets for medical AI training and research. The seed round is led by Peak XV Partners, Afore Capital, DCVC, Emerson Collective, SV Angel, Verdict Capital, Streamlined Ventures, and Y Combinator. Capital will fund US and international expansion, including India, Brazil, and Argentina, as well as tech scaling and hiring. The company works with hospitals in the US and South America, and connects cancer patients to investigational vaccine programs in India.
Key points
- Seed round: $9.5M led by Peak XV, DCVC, Y Combinator
- Platform aggregates clinical data to train medical AI models
- Operating in US, Brazil, Argentina, and India; focuses on data infrastructure for healthcare AI
Summary and key points written by AI from the headline and a short excerpt, so they can be incomplete or wrong. Inc42 did the reporting; read the original for the full story.
Read the full story at Inc42
